These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

199 related items for PubMed ID: 38872171

  • 1. Monogenic hypertriglyceridemia and recurrent pancreatitis in a homozygous carrier of a rare APOA5 mutation: a case report.
    Makhmudova U, Schulze PC, Lorkowski S, März W, Geiling JA, Weingärtner O.
    J Med Case Rep; 2024 Jun 14; 18(1):278. PubMed ID: 38872171
    [Abstract] [Full Text] [Related]

  • 2. Evaluation of efficacy and safety of antisense inhibition of apolipoprotein C-III with volanesorsen in patients with severe hypertriglyceridemia.
    D'Erasmo L, Gallo A, Di Costanzo A, Bruckert E, Arca M.
    Expert Opin Pharmacother; 2020 Oct 14; 21(14):1675-1684. PubMed ID: 32646313
    [Abstract] [Full Text] [Related]

  • 3. Pharmacological treatment options for severe hypertriglyceridemia and familial chylomicronemia syndrome.
    Chaudhry R, Viljoen A, Wierzbicki AS.
    Expert Rev Clin Pharmacol; 2018 Jun 14; 11(6):589-598. PubMed ID: 29842811
    [Abstract] [Full Text] [Related]

  • 4. Rare Variants in Triglycerides-Related Genes Increase Pancreatitis Risk in Multifactorial Chylomicronemia Syndrome.
    Paquette M, Amyot J, Fantino M, Baass A, Bernard S.
    J Clin Endocrinol Metab; 2021 Aug 18; 106(9):e3473-e3482. PubMed ID: 34019660
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Volanesorsen in the Treatment of Familial Chylomicronemia Syndrome or Hypertriglyceridaemia: Design, Development and Place in Therapy.
    Esan O, Wierzbicki AS.
    Drug Des Devel Ther; 2020 Aug 18; 14():2623-2636. PubMed ID: 32753844
    [Abstract] [Full Text] [Related]

  • 8. Spectrum of Mutations and Long-Term Clinical Outcomes in Genetic Chylomicronemia Syndromes.
    D'Erasmo L, Di Costanzo A, Cassandra F, Minicocci I, Polito L, Montali A, Ceci F, Arca M.
    Arterioscler Thromb Vasc Biol; 2019 Dec 18; 39(12):2531-2541. PubMed ID: 31619059
    [Abstract] [Full Text] [Related]

  • 9. Incidental finding of severe hypertriglyceridemia in children. Role of multiple rare variants in genes affecting plasma triglyceride.
    Buonuomo PS, Rabacchi C, Macchiaiolo M, Trenti C, Fasano T, Tarugi P, Bartuli A, Bertolini S, Calandra S.
    J Clin Lipidol; 2017 Dec 18; 11(6):1329-1337.e3. PubMed ID: 28951076
    [Abstract] [Full Text] [Related]

  • 10. Volanesorsen: A New Era in the Treatment of Severe Hypertriglyceridemia.
    Kolovou G, Kolovou V, Katsiki N.
    J Clin Med; 2022 Feb 13; 11(4):. PubMed ID: 35207255
    [Abstract] [Full Text] [Related]

  • 11. Severe hypertriglyceridaemia and pancreatitis in a patient with lipoprotein lipase deficiency based on mutations in lipoprotein lipase (LPL) and apolipoprotein A5 (APOA5) genes.
    Koopal C, Bemelmans R, Marais AD, Visseren FL.
    BMJ Case Rep; 2019 Apr 03; 12(4):. PubMed ID: 30948399
    [Abstract] [Full Text] [Related]

  • 12. Familial Chylomicronemia Syndrome: A Clinical Guide For Endocrinologists.
    Falko JM.
    Endocr Pract; 2018 Aug 03; 24(8):756-763. PubMed ID: 30183397
    [Abstract] [Full Text] [Related]

  • 13. Familial chylomicronemia syndrome: an under-recognized cause of severe hypertriglyceridaemia.
    Baass A, Paquette M, Bernard S, Hegele RA.
    J Intern Med; 2020 Apr 03; 287(4):340-348. PubMed ID: 31840878
    [Abstract] [Full Text] [Related]

  • 14. Extreme hypertriglyceridemia: Genetic diversity, pancreatitis, pregnancy, and prevalence.
    Chyzhyk V, Kozmic S, Brown AS, Hudgins LC, Starc TJ, Davila AD, Blevins TC, Diffenderfer MR, He L, Geller AS, Rush C, Hegele RA, Schaefer EJ.
    J Clin Lipidol; 2019 Apr 03; 13(1):89-99. PubMed ID: 30352774
    [Abstract] [Full Text] [Related]

  • 15. Treatment of chylomicronemia.
    Navarro Hermoso A, Valdivielso P.
    Clin Investig Arterioscler; 2021 May 03; 33 Suppl 2():75-79. PubMed ID: 34006359
    [Abstract] [Full Text] [Related]

  • 16. Characterizing familial chylomicronemia syndrome: Baseline data of the APPROACH study.
    Blom DJ, O'Dea L, Digenio A, Alexander VJ, Karwatowska-Prokopczuk E, Williams KR, Hemphill L, Muñiz-Grijalvo O, Santos RD, Baum S, Witztum JL.
    J Clin Lipidol; 2018 May 03; 12(5):1234-1243.e5. PubMed ID: 30318066
    [Abstract] [Full Text] [Related]

  • 17. A Comprehensive Update on the Chylomicronemia Syndrome.
    Goldberg RB, Chait A.
    Front Endocrinol (Lausanne); 2020 May 03; 11():593931. PubMed ID: 33193106
    [Abstract] [Full Text] [Related]

  • 18. Familial chylomicronemia syndrome: A rare but devastating autosomal recessive disorder characterized by refractory hypertriglyceridemia and recurrent pancreatitis.
    Chyzhyk V, Brown AS.
    Trends Cardiovasc Med; 2020 Feb 03; 30(2):80-85. PubMed ID: 31003756
    [Abstract] [Full Text] [Related]

  • 19. A Clinical Case of a Homozygous Deletion in the APOA5 Gene with Severe Hypertriglyceridemia.
    Vasiluev PA, Ivanova ON, Semenova NA, Strokova TV, Taran NN, Chubykina UV, Ezhov MV, Zakharova EY, Dadli EL, Kutsev SI.
    Genes (Basel); 2022 Jun 14; 13(6):. PubMed ID: 35741823
    [Abstract] [Full Text] [Related]

  • 20. Breaking the chains of lipoprotein lipase deficiency: A pediatric perspective on the efficacy and safety of Volanesorsen.
    den Hollander B, Brands MM, Nijhuis IJM, Doude van Troostwijk LJAE, van Essen P, Hofsteenge GH, Koot BG, Müller AR, Tseng LA, Stroes ESG, van de Ven PM, Wiegman A, van Karnebeek CDM.
    Mol Genet Metab; 2024 May 14; 142(1):108347. PubMed ID: 38401382
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.